• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对胶质瘤肿瘤发生的癌症干细胞模型的见解。

Insights into the cancer stem cell model of glioma tumorigenesis.

作者信息

Tang Carol, Chua Constance L M, Ang Beng-Ti

机构信息

Department of Research, National Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore 308433.

出版信息

Ann Acad Med Singap. 2007 May;36(5):352-7.

PMID:17549283
Abstract

Not all cancer cells are born equal. While the great majority of the cells that make up tumours are destined to differentiate, albeit aberrantly, and eventually stop dividing, a handful of cancer cells appear to possess limitless replicative potential. This review presents compelling evidence to suggest that the bulk of malignant cells of most cancers are generated by a rare fraction of stem cell-like cancer cells. These cells, dubbed cancer stem cells, are phenotypically similar to the normal stem cells of the corresponding tissue of origin, but they exhibit dysfunctional patterns of self-renewal and differentiation. Cancer stem cells that are capable of recapitulating brain tumours as xenografts in mice are characterised by defined stem cell markers. These brain tumour stem cells demonstrate enhanced chemoresistance and radioresistance mechanisms compared to non-stem cells in the heterogeneous tumour, which suggest that they may be the likely candidates for tumour progression and recurrence. Indeed, recent work has shown that such aberrant signalling pathways may be targeted in novel anti-cancer therapeutic strategies. The stem cell concept of tumour progression prompts immediate attention to a new paradigm in cancer research with a focus on this minority subset of cells, and the design of novel therapeutic strategies to target these cells that are insignificant within the population of tumour cells, but that are in fact the relevant cells to be destroyed.

摘要

并非所有癌细胞都是生来平等的。构成肿瘤的绝大多数细胞尽管会异常分化,但最终会停止分裂,然而仍有少数癌细胞似乎具有无限的复制潜能。这篇综述提供了令人信服的证据,表明大多数癌症的大部分恶性细胞是由一小部分干细胞样癌细胞产生的。这些细胞被称为癌症干细胞,在表型上与相应起源组织的正常干细胞相似,但它们表现出自我更新和分化的功能失调模式。能够在小鼠体内作为异种移植重现脑肿瘤的癌症干细胞具有特定的干细胞标志物。与异质性肿瘤中的非干细胞相比,这些脑肿瘤干细胞表现出更强的化学抗性和放射抗性机制,这表明它们可能是肿瘤进展和复发的潜在候选者。事实上,最近的研究表明,这种异常的信号通路可能是新型抗癌治疗策略的靶点。肿瘤进展的干细胞概念促使人们立即关注癌症研究中的一个新范式,即关注这一少数细胞亚群,并设计针对这些细胞的新型治疗策略,这些细胞在肿瘤细胞群体中所占比例微不足道,但实际上却是需要被消灭的相关细胞。

相似文献

1
Insights into the cancer stem cell model of glioma tumorigenesis.对胶质瘤肿瘤发生的癌症干细胞模型的见解。
Ann Acad Med Singap. 2007 May;36(5):352-7.
2
Cancer stem cell: target for anti-cancer therapy.癌症干细胞:抗癌治疗的靶点。
FASEB J. 2007 Dec;21(14):3777-85. doi: 10.1096/fj.07-8560rev. Epub 2007 Jul 11.
3
Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations.异质性胶质瘤干细胞群体自我更新中幂律生长的发现。
PLoS One. 2015 Aug 18;10(8):e0135760. doi: 10.1371/journal.pone.0135760. eCollection 2015.
4
[Tumour stem cells in glioma--tomorrow's therapeutic target?].[胶质瘤中的肿瘤干细胞——未来的治疗靶点?]
Ugeskr Laeger. 2008 Sep 15;170(38):2968-70.
5
Mouse induced glioma-initiating cell models and therapeutic targets.鼠诱导的神经胶质瘤起始细胞模型和治疗靶点。
Anticancer Agents Med Chem. 2010 Jul;10(6):471-80. doi: 10.2174/1871520611009060471.
6
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.由MLL-AF9引发的从定向祖细胞向白血病干细胞的转变。
Nature. 2006 Aug 17;442(7104):818-22. doi: 10.1038/nature04980. Epub 2006 Jul 16.
7
Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.人类非小细胞肺癌表达假定的癌症干细胞标志物,并表现出多能细胞的转录组特征。
BMC Cancer. 2015 Feb 25;15:84. doi: 10.1186/s12885-015-1086-3.
8
Reversing breast cancer stem cell into breast somatic stem cell.将乳腺癌干细胞逆转成乳腺体干细胞。
Curr Pharm Biotechnol. 2011 Feb 1;12(2):189-95. doi: 10.2174/138920111794295819.
9
Brain tumour stem cells: possibilities of new therapeutic strategies.脑肿瘤干细胞:新治疗策略的可能性
Expert Opin Biol Ther. 2007 Aug;7(8):1129-35. doi: 10.1517/14712598.7.8.1129.
10
Characteristics of glioma stem cells.神经胶质瘤干细胞的特征。
Brain Tumor Pathol. 2013 Oct;30(4):209-14. doi: 10.1007/s10014-013-0141-5. Epub 2013 Apr 13.

引用本文的文献

1
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED).一项1期概念验证研究,评估在晚期或转移性乳腺癌中(EPI-PRIMED研究)将赖氨酸特异性去甲基化酶1(LSD1)抑制剂添加至白蛋白结合型紫杉醇的疗效。
Front Oncol. 2022 Jun 3;12:862427. doi: 10.3389/fonc.2022.862427. eCollection 2022.
2
Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.白蛋白紫杉醇(Abraxane)纳米粒减少,而紫杉醇增加三阴性乳腺癌治疗中的乳腺癌干细胞。
Mol Pharm. 2020 Jul 6;17(7):2275-2286. doi: 10.1021/acs.molpharmaceut.9b01221. Epub 2020 Jun 17.
3
Anticancer activity of a monobenzyltin complex C1 against MDA-MB-231 cells through induction of Apoptosis and inhibition of breast cancer stem cells.
单苄基锡配合物 C1 通过诱导细胞凋亡和抑制乳腺癌干细胞对 MDA-MB-231 细胞的抗癌活性。
Sci Rep. 2016 Dec 15;6:38992. doi: 10.1038/srep38992.
4
Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.山油柑碱,一种来自九里香(Murraya koenigii (L) Spreng)的天然膳食化合物:对MCF7乳腺癌细胞的抑制作用以及对衍生的MCF7乳腺癌干细胞(CD44(+)/CD24(-/low))的靶向作用:一项体外研究。
Drug Des Devel Ther. 2015 Feb 24;9:1193-208. doi: 10.2147/DDDT.S72127. eCollection 2015.
5
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma.高穿透性载药纳米载体改善胶质母细胞瘤治疗效果。
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11751-6. doi: 10.1073/pnas.1304504110. Epub 2013 Jul 1.
6
The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?癌症干细胞在乳腺癌转移器官嗜性中的作用:“种子”与“土壤”之间的机制平衡?
Int J Breast Cancer. 2012;2012:209748. doi: 10.1155/2012/209748. Epub 2011 Nov 3.
7
Novel delivery strategies for glioblastoma.用于胶质母细胞瘤的新型递药策略。
Cancer J. 2012 Jan-Feb;18(1):89-99. doi: 10.1097/PPO.0b013e318244d8ae.
8
Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells.葫芦素I对磷酸化STAT3的抑制作用增强了髓母细胞瘤来源的癌症干细胞的放化疗敏感性。
Childs Nerv Syst. 2012 Mar;28(3):363-73. doi: 10.1007/s00381-011-1672-x. Epub 2012 Jan 17.
9
The changing role of pathology in breast cancer diagnosis and treatment.病理学在乳腺癌诊断和治疗中的角色变化。
Pathobiology. 2011;78(2):99-114. doi: 10.1159/000292644. Epub 2011 Jun 14.
10
Study on the proliferation and drug-resistance of human brain tumor stem-like cells.人源脑肿瘤干细胞的增殖与耐药性研究。
Cell Mol Neurobiol. 2010 Aug;30(6):955-60. doi: 10.1007/s10571-010-9525-9. Epub 2010 Jun 6.